Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.
All fine and dandy, Ophidian. I am a chartist myself but you know that at present we have or had a large seller in the market and the company made a complete and utter FU of the CE application both of which are major negative factors. Until we get some significant positive news, hopefully on 21st, your hopes for a major upside breakout are for the birds.
Smith HAS to deliver at the Business Update else all major support levels will quickly collapse - and you know it.
Today’s RNS was a disgrace. The 10 May RNS clearly stated that the data and CE submission had been made to the MHRA. We are now told there was an ‘error’ and it was not then made. This is pure obfuscation. Either Mologic mislead Avacta or someone at the company was grossly incompetent in not checking the facts before the earlier RNS was released. We need to know the facts behind this mess.
Yes, cracking results. But it has to be remembered that they are due to Covid and the creation of the Infectious Diseases Testing unit with margins of nearly 40% serving 2 main customers - DHS and Spire Health. Notwithstanding, it is most encouraging that the Exec Chair saying that the current year will see 'aggressive growth' and that the IDT unit will be expanded to cover other technologies and locations.
A bargain, I think as all the evidence is that Covid is likely to be around for quite some time - look at Brazil..........
Silly comment. AS will not be able to prevent a takeover - he only has 2.5% of the share capital including options. The directors can only advise shareholders what action to take if an approach is made for the company but if it is generous enough, shareholders might vote for the bird in hand. But I would not accept!!
http://digitaleditions.telegraph.co.uk/data/559/reader/reader.html?social#!preferred/0/package/559/pub/559/page/2/article/159478
Tomorrow is going to be massive!
Agree your analysis - I have been following this ‘ channel’ pattern for months now. It is a pretty clear expectation that the opening SP will ‘gap’ much higher and on good volume which are both excellent indicators. Around £3.20 is a minimum target!!
Chartists will know that this is a very reliable predictive pattern.
Re Bioquell, if you look at the history of Bioquell you will see that Harwood had a major stake. It was not performing very well and then Ian Johnson was appointed executive chairman and Michael Roller joined as FD. They transformed the business and it was eventually taken over early 2019 for a whopping profit compared with the position when Johnson joined.
The same seam are now in place at Circassia with Harwood behind them. Look out for similar fireworks in my view.
I agree all the positive comments here. The share chart looks great - a lovely base formation and strong pull away on good volume. 50/60p easily in the medium term. Note that Harwood Capital and Lombard Odier are stuffing themselves with the shares.
Also, it is significant in my view that the team that went into Bioquell (smashing profit that one!) has now gone into Circ - I think we can expect a similar outcome. BUY, BUY, BUY.
Someone has got wind of the fact that the Greenlane deal is in the bag! With this millstone out of the way, Pres will return to its roots and be a specialist engineer making nice, healthy cash profits - hopefully.
TruroTrader is right to love Foxy - have a good look at the chart. If that is not the base of a 'triple bottom' having been worked out over the last 2 years, then I will give up technical analysis. I tried to buy in volume today and simply could not.
The implications of this sort of chart pattern are very positive indeed.
ticking up nicely - chart indicates move to around 20p......... watch this space
My guess is that 2018 should see PBT at around �4.2m which would give a forecast PER of around 25 for a company growing strongly and generating piles of cash. The PER is NOT 257 in reality!
Just a thought - has the current weakness in the SP got anything to do with the possible demise of Carillion? I could easily imagine that CLLN might be a big customer of AGK for generator/power bank rental and if it folds there will be a rather large bad debt. Does anyone have any input on this comment? In any event, the AGK is nearing a critical point on the charts. If it closes below 760p or thereabouts, there will be a massive fall
For devotees of the dark art of technical analysis or 'charting', the Fox price is at a critical point. Should it move through the present level on reasonable volume, then 16.5p should be easily attainable. In any event, the recent Beaufort write up and quite remarkable unsecured loan (especially given the relatively small shareholding of the director involved) both add substantial credibility to the strong buy case. Keep an eye on the chart!!
You cynical ba****d. Can't you give some credit for a little progress. I think you will regret your comment come 12 months time.
Someone seems very keen today, having paid top £ for 200,000 shares! Wow!
Question for Gilbert There is a First Gazette notice for compulsory strike-off of Eboracum Marble dated 17 January 201. Doesn't this suggest that this company does not have any meaningful assets or business that Fox can rely on for orders despite previous announcements about its potential?